Peter Cicala

Insider Reports History

Identity Who this page is about. 1 identity field
Location
Cambridge, MA
SEC source record Original filing metadata and source links. 1 source field
Owner filing signature
/s/ Peter Cicala
Source evidence Original filing metadata and source links. 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Peter Cicala

Form 4 holding Director

Eterna Therapeutics Inc.

Security class
Stock Option (Right to buy)
Shares / value
51,485
Estimated value
Report date
07 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Peter Cicala

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .